Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
about
Roles of bacterial and mammalian siderophores in host-pathogen interactionsAging and the disposition and toxicity of mercury in rats.Mesenchymal stem cells correct haemodynamic dysfunction associated with liver injury after extended resection in a pig model.Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients.A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalinA p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury.Novel Hg2+-induced nephropathy in rats and mice lacking Mrp2: evidence of axial heterogeneity in the handling of Hg2+ along the proximal tubule.Urinary neutrophil gelatinase-associated lipocalin in critically ill surgical cancer patients.Urinary neutrophil gelatinase-associated lipocalin (NGAL) might be an independent marker for anticipating scar formation in children with acute pyelonephritis.Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver DiseaseUrine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice.Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep ApneaMolecular phenotyping of clinical AKI with novel urinary biomarkers.Significance of Neutrophil Gelatinase-Associated Lipocalin Level-to-Serum Creatinine Ratio for Assessing Severity of Inflammation in Patients with Renal Dysfunction.Administration of HES in elderly patients undergoing hip arthroplasty under spinal anesthesia is not associated with an increase in renal injury.Independent associations of urine neutrophil gelatinase-associated lipocalin and serum uric acid with interstitial fibrosis and tubular atrophy in primary glomerulonephritis.Neutrophil Gelatinase-Associated Lipocalin in Dogs With Sepsis Undergoing Emergency Laparotomy: A Prospective Case-Control Study.Serum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet.Effects of Therapy on Urine Neutrophil Gelatinase-Associated Lipocalin in Nondiabetic Glomerular Diseases with Proteinuria.Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial.Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malariaContrast media viscosity versus osmolality in kidney injury: lessons from animal studies.Bedside biomarkers in pediatric cardio renal injuries in emergency.Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.Effects of atorvastatin on biomarkers of acute kidney injury in amikacin recipients: A pilot, randomized, placebo-controlled, clinical trial.Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis.Understanding and preventing contrast-induced acute kidney injury.Rat Urinary Osteopontin and Neutrophil Gelatinase-Associated Lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury.Association of the cystatin C/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study.Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study.Novel acute kidney injury biomarkers: their characteristics, utility and concerns.Is urinary neutrophil gelatinase-associated lipocalin able to predict acute kidney injury episodes in very low birth weight infants in clinical settings?Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights.Dynamics of neutrophil gelatinase-associated lipocalin plasma and cerebrospinal fluid concentrations in older males.Neutrophil Gelatinase-Associated Lipocalin: A Biomarker for Early Diagnosis of Urinary Tract Infections in Infants.Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats.Waterworks.
P2860
Q26784135-6DB81D2A-0D8D-4BD4-9619-80EFEA2BC5A1Q33603202-B3E393C1-2453-4B90-BEFB-D6A53E6BC8FEQ33753118-34901085-1CF6-48CC-87D2-22F8D711B74EQ33761707-37DFBFC9-0DA7-4D69-ACAF-5D191A92FC18Q34088928-21427E84-8A3A-4F7D-BA94-1EAA905AA972Q34217270-7F45ED2C-50F5-4F66-8126-B95CC8D60C7CQ35085128-BB88752D-8B10-46D2-99E3-ECB7931911B1Q35102619-B1F27264-F61E-4976-A9D2-37895AF9785DQ35603735-E5F3F2CA-AC44-42A0-9982-063A53DB9EFFQ35694875-1ACD2A13-B114-4E6C-8956-07A82199106AQ35843192-015C7023-5758-44E4-B014-C5BA146C19F6Q35908335-A6DC1626-2F65-481B-87E1-6322AA336A04Q36009495-EA8319F5-2F29-468E-9298-221898D2BD80Q36017608-FA63244D-624D-49AE-BB88-0C2C1C40C324Q36146075-3B839BF2-2482-4493-AAA7-B6591D0C97F3Q36286621-6DD2A197-A0E5-48DF-AA6F-D3CEF2D0C3EBQ36838808-C0CA7DC8-9033-40F9-9DF6-FCC109EFBE42Q36975633-9CFEBD3A-8FBC-4813-94AD-8864E1DF254EQ37066380-62641E67-486D-4942-86AF-D348D8AB46BCQ37157018-34B23414-4EC1-4E0B-9338-20C0DDD5A99AQ37608257-5C1C25A0-0D07-4EF2-B610-8C1B3D81686AQ37609407-2DCB6B78-C06F-49FB-AA38-7171534C2B57Q37716666-1EC12289-66F2-4535-A86D-4CAE1C4EBEBFQ38202647-64BFEA82-654F-485D-9A65-92291D057F83Q38261952-1AECA1B4-ABDE-4320-8B55-76DAAD6B460BQ38383495-7F83BBD9-9EF2-4726-8BDD-E78C773957BCQ38807936-F28E2EEF-047E-4DFC-B5F5-F98C0299BDCAQ38836197-0A673141-0B75-49DF-91F7-59F523AD4C1AQ38849472-073C6362-421A-4343-BF39-0D711431CB90Q39110308-D736CD56-E60D-43E6-9F67-C7191DDA76ADQ39878923-B5814A4E-A4AA-4F51-848B-CB28A0360CA3Q40727867-2786976B-C07C-4F29-9365-C7DEAA50EEB5Q43826351-D41CCEF4-A646-4FAE-AE01-EF42656D54E1Q47226942-E07E756B-7C01-4526-9C40-E4C0AB441CB9Q47262052-99DBA26B-E151-40F8-8EC2-69ACD5B2163BQ47266173-6667A9CE-E332-4D37-848B-DCF092C4E876Q47589445-B749322B-BB92-440C-B8DE-6DAEE4ABE6F0Q47694560-BD153092-062A-44E8-B108-0927167665DDQ47931207-82FC522F-E062-41CC-867D-26565162FDC9Q52867608-E64B55F8-B5BE-47AA-87F3-5C6F39751EFD
P2860
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@ast
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@en
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@nl
type
label
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@ast
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@en
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@nl
prefLabel
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@ast
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@en
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@nl
P2093
P2860
P3181
P356
P1433
P1476
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications
@en
P2093
D. N. Müller
J. Barasch
K. M. Schmidt-Ott
P2860
P304
P3181
P356
10.1111/APHA.12054
P407
P577
2013-04-01T00:00:00Z